fda warning letters compounded semaglutide september 2025 issued 25 to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Targets GLP-1 and Peptide

Nausea is the #1 concern, and the most manageable

If gastrointestinal side effects are severe or persistent despite conservative measures, dose reduction or medication discontinuation should be considered in consultation with the prescribing physician

We take a different approach

While this early research was done with animals, the results are promising

Para nuseas matutinas, tmelos por la maana

How to Prevent Pancreatitis on GLP-1: Essential Insights for Safe Weight Loss Acute pancreatitis, characterized by sudden inflammation of the pancreas, is a serious condition that can lead to significant health complications